With more than 25 years at Kaiser Permanente Washington Health Research Institute (KPWHRI), Laura Ichikawa, MS, is known for her analytical skills, attention to detail regarding study design and data management, and expertise in data visualization. Her experience includes observational studies, randomized controlled trials, case-control studies, and multisite analyses.
Ms. Ichikawa is primarily focused on breast cancer and women’s health. She is involved in two large, multisite National Cancer Institute-funded projects: the Statistical Coordinating Center for the Breast Cancer Surveillance Consortium (BCSC) and a colorectal research site for Population-based Research to Optimize the Screening Process (PROSPR). Much of her work with the BCSC has been evaluating mammography performance and use of other imaging modalities such as MRI, or magnetic resonance imaging, especially after a breast cancer diagnosis. Ms. Ichikawa also participated in collaborative research through the Cancer Research Network, including a widely publicized 2004 study that linked not having screening mammograms to late-stage breast cancer. More recently, this work examined the association of chemotherapy use with peripheral neuropathy. Ms. Ichikawa is excited to continue her work in breast cancer research, including in screening, treatment, surveillance, and survival.
Ms. Ichikawa's research with retired KPWHRI Senior Investigator Delia Scholes, PhD, includes studies examining bone loss associated with the injectable hormonal contraceptive Depo-Provera in 2002 and 2005 and oral contraceptives in 2011. She continues to work in areas of women’s health and contraceptive methods.
Ms. Ichikawa is a member of the American Statistical Association and its Puget Sound chapter.
Treiman GS, Ichikawa L, Treiman RL, Cohen JL, Cossman DV, Wagner WH, Levin PM, Foran RF. Treatment of recurrent femoral or popliteal artery stenosis after percutaneous transluminal angioplasty. J Vasc Surg. 1994;20(4):577-85. PubMed
Buist DM, Ichikawa L, Wernli KJ, Lee CI, Henderson LM, Kerlikowske K, Bowles EJ, Miglioretti DL, Specht J, Rauscher G, Sprague B, Onega T, Lee JM. Facility variability in examination indication among women with prior breast cancer: implications and the need for standardization. J Am Coll Radiol. 2020 Jan 28. pii: S1546-1440(19)31483-8. doi: 10.1016/j.jacr.2019.12.020. [Epub ahead of print]. PubMed
New study results in more precise language in the federally mandated warning about this possibility.
A Kaiser Permanente-led BCSC study is among the largest ever to evaluate adding MRI surveillance for breast cancer survivors.
New KPWHRI study shows that women with simple cysts are not at increased risk of ovarian cancer.
Dr. Katherine Newton co-wrote JAMA Internal Medicine paper comparing vaginal estrogen, moisturizer, and placebo gel.